Copyright
©The Author(s) 2020.
World J Gastroenterol. Aug 21, 2020; 26(31): 4607-4623
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4607
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4607
Figure 4 The relative abundance of proline and hydroxypurine in hepatocellular carcinoma patients, cirrhosis patients and healthy controls.
A: Proline; B: Hydroxypurine. P < 0.05 in Kruskal-Wallis test in all three comparisons (C vs N, Y vs N, and C vs Y) of each metabolite.
- Citation: Zhou PC, Sun LQ, Shao L, Yi LZ, Li N, Fan XG. Establishment of a pattern recognition metabolomics model for the diagnosis of hepatocellular carcinoma. World J Gastroenterol 2020; 26(31): 4607-4623
- URL: https://www.wjgnet.com/1007-9327/full/v26/i31/4607.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i31.4607